FTC seeks more information on Boston Scientific's $3.7 bln Axonics deal

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Apr 04, 2024 at 11:02: AM
via Boston Scientific (BSX.N) said on Thursday the U.S. Federal Trade Commission (FTC) has requested additional information from the medical device maker related to its $3.7 billion deal to buy Axonics (AXNX.O), opens new tab.

article source
 

<



Similar threads

cafead
FTC seeks more information on Novo Nordisk parent-Catalent deal
Replies
0
Views
118
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FTC seeks additional info on Pfizer&#039;s proposed takeover of Seagen
Replies
0
Views
93
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Express Scripts sues FTC over drug pricing report
Replies
0
Views
5
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FTC poised to sue drug middlemen over insulin prices
Replies
0
Views
12
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FTC report finds PBM power has “dire consequences”
Replies
0
Views
24
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote